TTOO - T2 Biosystems, Inc.
| Previous Close | 3.8900 |
| Open | 3.8800 |
| Bid | 0.00 x 100 |
| Ask | 5.13 x 2500 |
| Day's Range | 3.8000 - 4.0500 |
| 52 Week Range | 3.7600 - 9.9800 |
| Volume | 321,997 |
| Avg. Volume | 498,369 |
| Market Cap | 172.632M |
| Beta (3Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.41 |
| Earnings Date | Feb 12, 2018 - Feb 16, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.50 |
- GlobeNewswire•10 days ago
T2 Biosystems Reports Granting of Inducement Awards
The inducement awards consist of options to purchase 29,000 shares of T2 Biosystems common stock and have a ten-year term. The exercise price of the options is $4.45, which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on December 4, 2018.
- GlobeNewswire•18 days ago
New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Nov. 29, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Simply Wall St.•last month
How Many T2 Biosystems Inc (NASDAQ:TTOO) Shares Do Institutions Own?
A look at the shareholders of T2 Biosystems Inc (NASDAQ:TTOO) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge Read More...
- Thomson Reuters StreetEvents•last month
Edited Transcript of TTOO earnings conference call or presentation 1-Nov-18 8:30pm GMT
Q3 2018 T2 Biosystems Inc Earnings Call
- Zacks•last month
Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
- Zacks•last month
Bet on Rising P/E Investing With These 5 Top-Ranked Stocks
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
- GlobeNewswire•last month
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
T2 Biosystems, Inc. (TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is scheduled to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum. The conference is being held on November 15 at the Westin Grand Central in New York. Mr. McDonough and John Sprague, chief financial officer, will be available for one-on-one meetings during the conference.
- GlobeNewswire•last month
T2 Biosystems Reports Granting of Inducement Awards
The inducement awards consist of options to purchase 23,500 shares of T2 Biosystems common stock and have a ten-year term. The exercise price of the options is $5.28, which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on November 1, 2018.
- Associated Press•last month
T2 Biosystems: 3Q Earnings Snapshot
On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 25 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
- GlobeNewswire•2 months ago
Consolidated Research: 2018 Summary Expectations for Vuzix, BCE, Tetraphase Pharmaceuticals, T2 Biosystems, TPG Specialty Lending, and Jianpu Technology — Fundamental Analysis, Key Performance Indications
NEW YORK, Oct. 22, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- GlobeNewswire•2 months ago
T2 Biosystems Announces 2018 Third Quarter Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., Oct. 18, 2018 -- T2 Biosystems, Inc. (Nasdaq: TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical.
- GlobeNewswire•2 months ago
T2 Biosystems Reports Granting of Inducement Awards
The inducement awards consist of options to purchase 16,500 shares of T2 Biosystems common stock and have a ten-year term. The exercise price of the options is $6.82, which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on October 2, 2018.
- GlobeNewswire•2 months ago
T2 Biosystems Announces Customer Presentations at October Conferences
LEXINGTON, Mass., Oct. 03, 2018 -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical.
- Motley Fool•3 months ago
Here's Why T2 Biosystems Rose as Much as 16% Today
The diagnostic innovator provided performance data for a product pipeline candidate aimed at diagnosing Lyme disease.
- GlobeNewswire•3 months ago
New Data Suggests T2 Biosystems’ T2Lyme™ Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease
T2 Biosystems, Inc. (TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today new data suggesting the T2Lyme Panel™ is more accurate than other diagnostics for identifying Borrelia infections for patients suspected of having early Lyme disease. Run on the fully automated FDA-cleared T2Dx® Instrument, the T2Lyme Panel is designed to detect Lyme disease-causing bacteria in 3 to 5 hours. The data from a 2017 pre-clinical study evaluated 21 patients enrolled with an erythema migrans (EM) rash with suspected early Lyme disease and assessed with multiple Lyme diagnostics.
- Simply Wall St.•3 months ago
Should T2 Biosystems Inc’s (NASDAQ:TTOO) Recent Earnings Worry You?
When T2 Biosystems Inc (NASDAQ:TTOO) released its most recent earnings update (30 June 2018), I wanted to understand how these figures stacked up against its past performance. The two benchmarksRead More...
- Thomson Reuters StreetEvents•4 months ago
Edited Transcript of TTOO earnings conference call or presentation 2-Aug-18 8:30pm GMT
Q2 2018 T2 Biosystems Inc Earnings Call
- Associated Press•4 months ago
T2 Biosystems: 2Q Earnings Snapshot
On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 32 cents. The results matched Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
